Purpose: The lack of long-term patency of synthetic vascular grafts currently available on the market has directed research towards improving the performance of small diameter grafts. Improved radial compliance matching and tissue ingrowth into the graft scaffold are amongst the main goals for an ideal vascular graft.
Introduction
Regenerative medicine has emerged as one of the most dynamic drivers in the development of advanced engineered biomaterial solutions for tissue engineering applications. 5, 23 One crucial element in regenerative medicine is scaffolds that facilitate and guide the engineering and regeneration of biological tissues according to the application.
The ideal scaffold facilitates tissue engineering and regeneration such that the new tissue constructs biologically and mechanically mimic the healthy host tissue. 5 In cardiovascular regenerative therapies, one of the major challenges remains small-diameter vascular grafts. 28 For these grafts, a key factor for the long term success is porosity. 28 One method of introducing porosity in scaffolds for the vascular tissue engineering is electrospinning of polymers. 2, 3, 6, 7, 9, 10, 12-14, 16, 17, 21 For electrospinning of polymeric networks, the process parameters allow controlling the degree of fibre alignment 1, 25 which affects the mechanical properties of the fibrous scaffold. Scaffolds with fibres randomly distributed typically exhibit similar properties in different directions whereas the alignment of fibres predominantly in one direction introduces mechanical anisotropy. 1 Electrospun scaffolds with a high degree of fibre alignment exhibit a higher elastic modulus, i.e. stiffness, in fibre direction and a lower elastic modulus perpendicular to the fibre direction. The directional mechanical properties of the scaffold can be utilised to tailor structural properties. They add, however, complexity to the design process which needs to be adequately addressed.
Another factor that influences the structural and mechanical properties of the scaffold is the ingrowth of cells and tissue -whether through in vitro tissue culture or after implantation. When optimising scaffold-based engineered tissue constructs, the structural contribution of the new tissue should be considered in the design of the original scaffold. The incorporation of tissue in the scaffold is a transient process. As such, a gradual change of the mechanical properties of the scaffold-tissue construct is expected until tissue ingrowth and maturation is complete. Biomechanical properties of scaffolds are predominantly obtained prior to tissue culturing or implantation 2, 4, 13, 27 whereas the changes in mechanical properties due to tissue ingrowth after implantation have received very little attention.
Materials and Methods

Scaffold material
Pellethane© 2363-80AE (Dow Chemicals, USA), a medical grade aromatic poly(ether urethane) with a hard segment consisting of 4,4-methylenebis(phenylisocyanate) and 1,4-butanediol and a soft segment of poly(tetramethylene oxide) glycol (Mn = 1000 g/mole) 19 was used. 
Electrospinning and sample preparation
A 15 wt% Pellethane© solution was obtained by dissolving 8 g of Pellethane© pellets in 45.3 g of tetrahydrofuran (THF, Sigma Aldrich, Steinheim, Germany) at 37°C for 8 hours. Using a custommade rig, the Pellethane® solution was electrospun from a hypodermic needle (SE400B syringe pump, Fresenius, Bad Homburg, Germany) onto a rotating and bi-directionally translating tubular target (hypodermic tubing, Small Parts, Loganport, IN, USA). The spinning process parameters were, for subcutaneous and circulatory samples, respectively: solution flow rate of 6 and 4.8 mL/h, target outer diameter of 25.0 and 2.2 mm, target rotating speed of 4400 and 9600 rpm, target translational speed of 2.6 mm/min, electrostatic field of 13 and 15 kV, and source-target distance of 250 mm (Note: Parameters were the same if only one value is given).
After completion of the spinning process, the electrospun structure on the target hypotube was submersed in ethanol for 5 minutes, removed from the mandrel and dried under vacuum (Townson & Mercer Ltd, Stretford, England; room temperature, 90 min) and trimmed on either end to discard regions with decreasing wall thickness. For subcutaneous implants, tubular scaffolds were cut into 9 × 18 mm rectangular samples with the longer edge aligned with either the circumferential (C) or axial (A) tube direction. For circulatory implants, scaffold tubes were cut into 11 mm long pieces.
Samples were sterilised by submersion in 70% ethanol (room temperature, 24 h) and dried under vacuum (Townson & Mercer, Stretford, England, room temperature, 24 h). Samples for circulatory implants additionally underwent standard ETO sterilisation (55°C, 60% relative humidity, 12 h).
Physical characterisation of scaffold before implantation
Physical characterisation included microscopic analysis of fibre diameter and alignment, measurement of scaffold wall thickness and porosity. 24 The plug-in examines the power spectrum of Fourier transforms of the images in a polar coordinate system, measuring the power in user specified angular increments. A Gaussian function is fitted to the highest peak from which dispersion is calculated as the standard 5 deviation of the Gaussian. This dispersion factor was used as an indication of fibre alignment. Smaller values indicate greater alignment.
Fibre diameter and alignment
Scaffold and sample dimensions
Width, length and wall thickness of scaffold samples were measured on images captured on a Leica DFC280 stereo microscope using Leica IM500 imaging software (Leica Microsystems GmbH, Wetzlar, Germany). Six thickness measurements were recorded on both length edges of each sample as well as six measurements for sample width. The sample mass was determined using a Mettler Toledo XS105S analytical balance (Mettler Toledo, Greifensee, Switzerland).
Scaffold porosity
Scaffold porosity, P, was determined by hydrostatic weighing typically employed for density determination. The porosity of fibrous networks is described as volumetric ratio (1)
Expressing volumes as masses and considering that ethanol was used for hydrostatic weighing, providing meth.pores and meth.total, Eq. 1 can be rewritten as (
Introducing measurable quantities provides 
where mdry is the mass of the dry scaffold, msubmerged is the mass of the scaffold submerged in ethanol, and mwet is the mass of the scaffold after removal from the ethanol with ethanol retained in the pores. 
Equations 2 and 3 can be substituted as follows:
The porosity of each spun scaffold for each study was measured as described above with n = 1 per electrospun scaffold.
Study design
This study comprised subcutaneous and circulatory implants in a rat model with implant durations of 7, 14 and 28 days with n = 5 and 7 rats for subcutaneous and circulatory implant position, respectively, for each time point. For the subcutaneous implant position, each animal received five 6 implants, four for mechanical testing and one for histological analysis. For the circulatory position, each animal received one graft implant.
Scaffold implantation
All animal experiments were authorised by the Faculty of Health Sciences Research Ethics Committee of the University of Cape Town and were performed in accordance with the National Institutes of Health (NIH, Bethesda, MD) guidelines.
Male Wistar albino rats with body mass 200-250 g for subcutaneous implants and 350-400 g for circulatory implants were used. Anaesthesia was induced by placing the animal in an inhalation chamber with an air flow of 5% isoflurane for 5 min. The animals were shaved and sterilized with iodine in the area of the incision. Anaesthesia was maintained by nose cone delivery of 1.5% isoflurane at an oxygen output of 1.5 L/min at 1 bar and 21°C. The animal's body temperature was maintained throughout the surgical procedure by placing the animal on a custom-made heating pad at 37°C.
Subcutaneous implants
Five longitudinal incisions of 1 cm were made, two on one and three on the other side of the dorsal midline, and a pocket of 2 cm in depth was blunt dissected subcutaneously at each incision. Scaffold samples were placed within the pockets and incisions closed with silk 4/0 (Ethicon Inc, Somerville, NJ) interrupted sutures in a subcuticular fashion.
Circulatory graft implants
The aorta was exposed through a midline laparotomy and mobilised. Heparin was administered (1 mg/kg) prior to the cross-clamping of the aorta. The abdominal aorta was transected between the renal artery and the iliac bifurcation, the exposed aortic lumen was washed with heparin solution (1 mg/kg).
The graft was anastomosed with interrupted sutures (9/0 Ethilon, Johnson & Johnson, New Brunswick, NJ) using an operation microscope (Zeiss Universal S3, Oberkochen, Germany). The distal clamp was carefully released to de-air the graft, then the proximal clamp was released. If there was no bleeding, the abdomen was closed in two layers with continuous sutures (2/0 Ethibond, Johnson & Johnson, New Brunswick, NJ). Buprenorphine (0,1mg/kg) was administered subcutaneously before abdomen was closed, as well as for the first 3 days post operatively twice daily.
Implant retrieval
Anaesthesia was induced by placing the animal in an inhalation chamber with an air flow of 5% isoflurane for 5 min. 
Subcutaneous implants
Rats were euthanized by inhalation of 5% halothane in air followed by a cardiac injection of 1 ml saturated KCl solution. The samples with surrounding tissue were excised.
Circulatory graft implants
The abdominal area was shaved. Anaesthesia was maintained by nose cone delivery of 1.5% Isoflurane at an oxygen output of 1.5 l/min at 1 bar and 21°C. The graft implant site was exposed through a midline incision and dissected from adhesions. 1 mg/kg IV heparin was given via the inferior vena cava and allowed to circulate for 3 mins. The animal was then exsanguinated. After apnoea the chest was opened via sternotomy. A 20G cannula was inserted through the apex of the heart into the aorta. The aorta then was flushed with 200 ml NaCl 0.9% until clear fluid drained out of the opened right atrium. Perfusion fixation was performed with 100 ml paraformaldehyde. Thereafter the graft was excised and dissected in sections for mechanical testing and histological analysis.
Processing of retrieved samples
Samples for mechanical testing were submerged in phosphate buffered saline solution (PBS) and stored at 4°C. Samples for histological analysis underwent tissue fixation in 10% formalin (Sigma Aldrich, Steinheim, Germany) for 24 hours, after which they were stored in a 70% ethanol solution.
Mechanical testing
Prior to testing, the thickness, length and width of retrieved subcutaneous samples were determined with a calliper. For retrieved graft samples, the wall thickness and width were measured using a stereo microscope (Leica DFC280 and Leica IM500 imaging software, Leica Microsystems GmbH, Wetzlar, Germany) and calliper, respectively.
Tensile testing was performed within 12 hours of implant retrieval with samples submerged in PBS at 37°C (Instron 5544, 10 N load cell; Instron, Norwood, USA). Flat subcutaneous samples were fixed using custom made clamps resulting in a gauge length of approximately 10 mm. The direction of tensile load represented either circumferential (C) or axial direction (A) of the original tubular scaffold. Circulatory graft samples were placed over two custom pin holders (hypodermic needles, outer diameter 0.9 mm) and loaded in circumferential direction. The loading protocol comprised one initial extension to 12% strain, five cycles between 12% and 8% strain, and a final extension to failure or the load limit of the load cell of 7.4 N (whichever came first) for subcutaneous samples, and to 17% strain or the load limit of the load cell (whichever came first) for circulatory graft samples (crosshead speed: 20 mm/min). 
Histology
Statistical analysis
Data were assessed for normality using Shapiro-Wilk test. One-way ANOVA was performed when more than two groups were compared by using Tukey HSD post-hoc analysis with p < 0.05 indicating statistical significance. Data are provided as mean ± standard deviation. The scaffold for circulatory implantation exhibited fibres with considerable variation in thickness and random orientation. The low goodness factor of 0.72 of the fibre dispersion of 23 ± 9% (180° corresponds to a random distribution) indicated limited accuracy of the Gaussian fit for dispersion and suggested that fibres were more dispersed than the measured 23°. Similar to the subcutaneous scaffold, little fibre merging was observed, however the fibre surface was much smoother with substantial less dimpling. 
Results
Pre-implant scaffold morphology
Tissue ingrowth
Histological micrographs illustrating the ingrowth of tissue in the scaffold after 7, 14 and 28 days are provided in Figure 2 for subcutaneous implants and in Figure 3 for circulatory implants. Tissue ingrowth after 7, 14 and 28 days was 65.0 ± 13.0%, 87.3 ± 3.9% (p = 0.008) and 96.5 ± 2.3% (p = 0.001), respectively, for the subcutaneous position and 64.9 ± 9.8%, 74.3 ± 9.9% (not significant, ns) and 77.8 ± 5.4% (ns), respectively, for the aortic interposition (P values refer to comparison to t = 7 days). A decrease in gauge length of 22% was observed for subcutaneous samples implanted for 28 days compared to those implanted for 14 days despite a consistent pre-implant sample length for the entire study (18 ± 0.5 mm). Figure 4 (a) provides graphs of stress versus strain for the subcutaneous scaffold before implantation (0 day) and after 7, 14, and 28 days implant duration in circumferential and axial direction of the scaffold for a maximum strain of 25%. In circumferential direction, little change was observed from 0 to 7 and 14 days implant duration whereas there was a substantial decrease in stress after 28 days implantation. In axial scaffold direction, an increase of stress from pre-implant scaffold and implanted scaffolds was observed. Figure 4 (b) illustrates stress versus strain of up to 17% in circumferential 12 direction of the circulatory graft samples at 0, 7, 14, and 28 days implantation. For these samples, a significant increase in stress was observed from 0 to 7 days, whereas changes were smaller thereafter. Figure 5 shows stress at 12% and 16% strain and elastic modulus at 6% and 12% strain versus implant time in circumferential and axial scaffold directions for the subcutaneous implants (Figure 5 a, b) and in circumferential direction only for the circulatory implants (Figure 5 c, d) . In circumferential direction of the subcutaneous scaffold implants, stress was significantly lower after 28
Mechanical properties
days implantation compared to the 0 day pre-implant (p < 0.0005). The circulatory scaffold implants exhibited an increase of the elastic modulus at 6% strain by 147% (p < 0.005) and at 12% strain by 77% (ns) between T = 0 and 28 days (Figure 5 d) . 
Discussion
Tissue ingrowth into scaffolds was similar for the subcutaneous implants and the circulatory implants during the first 7 days. Thereafter, ingrowth was slower in the circulatory compared to the subcutaneous implants.
The difference in fibre thickness between the two scaffolds was most likely attributed to the different spinning target and rotational speed, as the uptake speed affects fibre thickness. 15 The fibres of the circulatory scaffold were smooth and did not exhibit the dimpled surface texture that was present in the subcutaneous scaffolds. With comparable porosities, these two aspects could have contributed to deeper tissue penetration in the subcutaneous implants compared to the circulatory implants.
However, the different characteristics of the implant sites were the more likely cause, as subcutaneous samples were not immediately exposed to mechanical loading and were not clotted with blood at the time of implant.
Morphological differences of the scaffolds were observed; the scaffolds for assessment in subcutaneous positions exhibited a substantially higher degree of fibre alignment than the graft scaffolds used in the circulatory position. The difference was attributed to larger diameter of the electrospinning mandrel used for subcutaneous scaffolds, resulting in higher velocities of fibre uptake and consequently fibre alignment, compared to that used for the scaffolds for circulatory interposition.
Ex vivo scaffold mechanics of subcutaneous implants
The decrease in circumferential stiffness between 14 to 28 days (Figure 5 b) was ascribed to increasing morphological disruption of the highly aligned scaffold by ingrowing tissue, facilitated by the low degree of fibre merging. Displacement of fibres by ingrowing tissue is mostly expected to occur in axial scaffold direction, i.e. transverse to circumferentially aligned fibres. This proposed mechanism is illustrated in Figure 6 . With progressing tissue ingrowth, the scaffold becomes increasingly compacted. The local realignment of the fibres during compaction leads to shortening of the scaffold in circumferential direction (as observed for samples of T = 28 days compared to T = 24 days) and an increase in structural stiffness (modulus) due to inhibition of local fibre realignment. The shortening of the scaffolds observed in the current study is slightly different from findings of van Vlimmeren et al. 20 for tissue engineered heart valves. They reported that tissue compaction was initiated when the biodegradable polyglycolic acid/poly-4-hydroxybutyrate scaffolds lost their mechanical integrity. As Pellethane® is biostable, the mechanical integrity of the scaffold did not change in vivo. The main cause for the two effects is, however, the same: ingrowing tissue exerts forces on the scaffold which modifies the scaffold geometry. Increase in axial stiffness with increasing implant duration (Figure 5 b) : A significant increase of the elastic modulus at 12% strain in axial scaffold direction between T = 0 and T = 28 days (p < 0.005) is based on the low elastic modulus in the scaffold pre-implantation transverse to the predominant fibre alignment, and the large mechanical contribution the ingrowing tissue provides relative to the low preimplant axial scaffold stiffness. The continuous increase in elastic modulus, although not statistically significant at 7 and 14 days, is ascribed to the progressive ingrowth of tissue observed.
Change in stress-strain behaviour with increasing implant duration: There was a change in shape of the stress-strain curves with the incorporation of tissue in the scaffold. At T = 0 days, the stress-strain curve is fairly linear, based only on the mechanical and structural properties of the fibrous scaffold.
From T=7 days onwards, the curves indicate non-linear stiffening in the 0-12% strain range (Figure   4 a), as is generally associated with tissue. 8, 11, 22, 26 The change from linear to non-linear elastic behaviour is reflected in a decrease in the elastic modulus at 6% strain of 41% and 29% and an increase in the elastic modulus at 12% strain of 11% and 41% from T = 0 days to 7 days and 14 days, respectively (Figure 5 b) . The change in the stress-strain response is attributed to the increasing contribution of ingrowing tissue to the mechanical behaviour of the scaffold, and the associated local changes in fibre alignment already discussed. Local displacement and de-alignment of fibres by newly formed tissue (Figure 6 b) leads to low stiffness associated with the wavy state of the fibres and higher stiffness once the fibres are straightened under increasing extension of the scaffold. The largest change in the elastic modulus compared to pre-implant time point was observed in the circumferential scaffold direction at 6% strain after 28 days of implantation.
Ex vivo scaffold mechanics of circulatory implants
An unexpected observation for the circulatory implants was that these scaffolds exhibited the maximum elastic modulus after 7 days of implantation. For the subcutaneous and the circulatory studies, samples retrieved at T = 7 days displayed more surrounding tissue than at 14 and 28 days.
Removing this tissue capsule without damaging the scaffold was more intricate for the vascular graft samples than for the flat samples. Remaining excess tissue is the most likely explanation for our finding. Disregarding the T = 7 days time point, the stress at 12% and 16% strain (Figure 5 c) and the elastic modulus at 6% strain increased gradually until 28 days implantation, whereas the elastic modulus at 12% strain increased until T = 14 days but did not change thereafter. Although not statistically significant, the elastic modulus increased with increasing strain from 6% to 12% by 39%, 11% and 45% at T = 0, 7 and 14 days, respectively, but did not increase at T = 28 days.
Conclusions
The softening of the highly aligned scaffold observed in the predominant fibre direction during formation of tissue poses a challenge in scaffold design. The scaffold softening not only limits the stiffness and strength of tissue engineered constructs; it also attenuates the mechanical anisotropy that may be desired for functional purposes. These effects may alter the desired long-term performance of the implants and need to be further studied.
